Short-Term Administration of the CCR5 Antagonist Vicriviroc to Patients With HIV and HCV Coinfection Is Safe and Tolerable
Gerd Fätkenheuer(University of Cologne), Dirk Schürmann(Humboldt-Universität zu Berlin), Anther Keung, Claudia Kasserra, Michelle Treitel, Jing Li(City Of Hope National Medical Center), Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), Edward O’Mara(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jihad Slim(Saint Michael's Medical Center), Angela Sansone‐Parsons
Cited by 8
Related Papers
Genome sequencing in microfabricated high-density picolitre reactors
|Nature|2005|7.7k
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients
|Clinical Infectious Diseases|2001|334
Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients.
|Journal of Clinical Oncology|1993|313